Shandong Sinobioway Biomedicine Co., Ltd. Profile Avatar - Palmy Investing

Shandong Sinobioway Biomedicine Co., Ltd.

Shandong Sinobioway Biomedicine Co., Ltd. manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, nerve growth factor, and alfaron in China. The company also provides NOBEX, a muri…
Chemicals - Specialty
CN, Zibo [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million CNY. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
54.00 85.00 74.00 63.00 83.00 80.00 137.00 169.00 271.00 74.00 48.00 18.00 -46.00 -54.00 -36.00
Operating Cash (Net)
54.00 85.00 74.00 63.00 83.00 80.00 137.00 169.00 271.00 74.00 48.00 18.00 -46.00 -54.00 -36.00
Accounts Receivable
- - - - - - -12.00 -46.00 -107.00 -163.00 -195.00 -127.00 118.00 49.00 106.00 75.00 46.00 69.00
Accounts Payable
- - - - - - - - - - - - - - -69.00 -15.00 -70.00 -28.00 73.00 -15.00 24.00 6.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-15.00 -24.00 -27.00 -59.00 -41.00 -17.00 497.00 -124.00 -113.00 -613.00 -66.00 -6.00 -55.00 -38.00 256.00
Capital Expenditure
-15.00 -29.00 -27.00 -62.00 -42.00 -20.00 -45.00 -44.00 -88.00 -608.00 -36.00 -67.00 -60.00 -31.00 -4.00
Purchases of Investments
- - - - - - - - - - 55.00 - - -80.00 -26.00 -155.00 -20.00 -60.00 -5.00 -50.00 - -
Sale/Maturity of Investment
- - - - - - - - - - - - - - - - - - 300.00 2.00 46.00 5.00 22.00 256.00
Property, Plant, Equipment (P&PE)
-15.00 -29.00 -27.00 -62.00 -42.00 -20.00 -45.00 -44.00 -88.00 -608.00 -36.00 -67.00 -60.00 -31.00 -4.00
Acquisitions (Net)
- - - - - - - - - - -32.00 - - - - - - - - - - - - - - 24.00 4.00
Other Investing Activities
- - 5.00 -27.00 2.00 - - -20.00 543.00 - - - - -150.00 -12.00 75.00 5.00 -3.00 260.00
Financing Activities
Used Cash (Net)
-46.00 -24.00 -405.00 -54.00 -54.00 -76.00 -131.00 -149.00 -886.00 -268.00 -463.00 -788.00 -5.00 -47.00 -211.00
Debt Repayment
-40.00 -40.00 -20.00 -19.00 -47.00 -84.00 -302.00 -162.00 -15.00 -100.00 -530.00 -875.00 -188.00 -229.00 -133.00
Dividends Paid
-46.00 -23.00 -43.00 -54.00 -54.00 -70.00 -16.00 -37.00 - - -75.00 -60.00 -55.00 -6.00 -8.00 -10.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Financing Activities
40.00 38.00 469.00 55.00 169.00 78.00 187.00 50.00 901.00 444.00 126.00 142.00 200.00 284.00 -67.00
Cash Balances
Begin of Period
49.00 41.00 78.00 531.00 480.00 467.00 370.00 873.00 769.00 1,812.00 1,542.00 1,060.00 284.00 187.00 142.00
End of Period
41.00 78.00 531.00 480.00 467.00 453.00 873.00 769.00 1,812.00 1,542.00 1,060.00 284.00 187.00 142.00 151.00
Change
-7.00 36.00 453.00 -50.00 -12.00 -13.00 503.00 -104.00 1,043.00 -270.00 -481.00 -776.00 -96.00 -45.00 9.00
Non-Cash Balances
Depreciation and Amortization
8.00 7.00 7.00 7.00 7.00 12.00 42.00 55.00 50.00 59.00 57.00 59.00 65.00 74.00 70.00
Stock Based Compensation
- - - - - - - - - - - - - - - - - - - - - - - - - - - - 15.00
Other
1.00 - - - - - - 1.00 -2.00 12.00 -8.00 -40.00 123.00 -91.00 -14.00 -456.00 -195.00 13.00
Highlighted metrics
Free Cash Flow (FCF)
38.00 56.00 47.00 - - 40.00 59.00 92.00 124.00 182.00 -533.00 12.00 -49.00 -106.00 -85.00 -40.00
Cash Conversion Cycle (CCC)
97.00 75.00 68.00 93.00 107.00 142.00 293.00 232.00 316.00 634.00 556.00 887.00 373.00 422.00 267.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of 002581.SZ's Analysis
CIK: - CUSIP: - ISIN: CNE1000012Y5 LEI: - UEI: -
Secondary Listings
002581.SZ has no secondary listings inside our databases.